413 filings
ARS
2023 FY
KTRA
Kintara Therapeutics Inc
17 May 24
Annual report to shareholders
4:10pm
DEF 14A
KTRA
Kintara Therapeutics Inc
Definitive proxy
17 May 24
4:05pm
425
KTRA
Kintara Therapeutics Inc
14 May 24
Business combination disclosure
4:55pm
8-K
KTRA
Kintara Therapeutics Inc
14 May 24
Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results
4:50pm
10-Q
2024 Q3
KTRA
Kintara Therapeutics Inc
Quarterly report
14 May 24
4:40pm
8-K
jwaw0kq9txv8wb
9 May 24
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
5:15pm
8-K
6azby7uxrlzk1ay
25 Apr 24
Regulation FD Disclosure
9:05am
425
h23sxf87f3tmiw2j3
25 Apr 24
Business combination disclosure
9:05am
425
at31pl
3 Apr 24
Business combination disclosure
7:15am
8-K
znepcsllpn31jstdf
3 Apr 24
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
7:09am
RW
euxx3wk9
13 Mar 24
Registration withdrawal request
7:00am
8-K
6puf9g7xw c47
27 Feb 24
Other Events
6:59am
8-K
yif89gwk2wgbw4ou24
26 Feb 24
Other Events
7:00am
8-K
qid9m02lvvizoo1y
22 Feb 24
Other Events
7:00am
8-K
lz5cng6oh856q
14 Feb 24
Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update
4:10pm
8-K
kob6uwm77bygm e8
12 Feb 24
Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer
9:05am
8-K
spwu9jl7 df4xxpkccp
18 Dec 23
Other Events
4:10pm
424B5
azjjh rlauh7g3fic
18 Dec 23
Prospectus supplement for primary offering
4:05pm